Home/Filings/4/0001213900-21-010660
4//SEC Filing

JACOB GARY S 4

Accession 0001213900-21-010660

CIK 0001708331other

Filed

Feb 18, 7:00 PM ET

Accepted

Feb 19, 6:22 PM ET

Size

4.8 KB

Accession

0001213900-21-010660

Insider Transaction Report

Form 4
Period: 2021-02-17
JACOB GARY S
Director
Transactions
  • Purchase

    Common Stock, $0.00001 par value

    2021-02-17$6.79/sh+3,500$23,7623,500 total
Footnotes (1)
  • [F1]This transaction was executed in multiple trades. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Documents

1 file

Issuer

Virpax Pharmaceuticals, Inc.

CIK 0001708331

Entity typeother

Related Parties

1
  • filerCIK 0001266802

Filing Metadata

Form type
4
Filed
Feb 18, 7:00 PM ET
Accepted
Feb 19, 6:22 PM ET
Size
4.8 KB